New frontiers in ASCVD risk reduction: integrating icosapent ethyl in clinical practice
Meeting report with slides, videos and CME course of a PACE-CME symposium at ESC 2022.
1
Episodes 1-3 of 3
- New frontiers in ASCVD risk reduction: integrating icosapent ethyl in clinical practice11 Practical implications of REDUCE-IT
Subodh Verma, MD, PhD
- New frontiers in ASCVD risk reduction: integrating icosapent ethyl in clinical practiceA continuum of multifactorial benefits of icosapent ethyl?
Prof. Magnus Bäck, MD, PhD
- New frontiers in ASCVD risk reduction: integrating icosapent ethyl in clinical practiceRecent clinical insights into icosapent ethyl
Deepak Bhatt, MD
